Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$429M |
| 2 |
Walt Disney
DIS
|
+$412M |
| 3 |
McDonald's
MCD
|
+$396M |
| 4 |
Goldman Sachs
GS
|
+$382M |
| 5 |
Electronic Arts
EA
|
+$320M |
Top Sells
| 1 |
Amazon
AMZN
|
+$2.12B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$619M |
| 3 |
AT&T
T
|
+$474M |
| 4 |
Synchrony
SYF
|
+$422M |
| 5 |
Honeywell
HON
|
+$366M |
Sector Composition
| 1 | Technology | 15.07% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 10.51% |
| 4 | Industrials | 9.53% |
| 5 | Consumer Discretionary | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Loews
L
$20.1B
| $1.16M | ﹤0.01% |
+24,093
| New | +$1.16M |
|
|
HDAW
2552
DELISTED
Xtrackers MSCI All World ex US High Dividend Yield Equity ETF
HDAW
| $1.16M | ﹤0.01% |
47,464
-14,152
| -23% | -$344K |
|
2553
Scorpio Tankers
STNG
$3.07B
| $1.15M | ﹤0.01% |
58,143
+40,830
| +236% | +$810K |
|
2554
Marten Transport
MRTN
$915M
| $1.15M | ﹤0.01% |
96,963
-126,761
| -57% | -$1.51M |
|
2555
Direxion Daily Technology Bear 3x Shares
TECS
$51.3M
| $1.15M | ﹤0.01% |
75
+37
| +97% | +$568K |
|
|
CEO
2556
DELISTED
CNOOC Limited
CEO
| $1.15M | ﹤0.01% |
6,196
+2,203
| +55% | +$409K |
|
2557
Alnylam Pharmaceuticals
ALNY
$59.2B
| $1.15M | ﹤0.01% |
12,304
-17,316
| -58% | -$1.62M |
|
2558
Invesco Dividend Achievers ETF
PFM
$732M
| $1.15M | ﹤0.01% |
41,611
-833
| -2% | -$23K |
|
|
CLLS
2559
Cellectis
CLLS
$309M
| $1.14M | ﹤0.01% |
62,366
+4,251
| +7% | +$78K |
|
2560
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
$1.22B
| $1.14M | ﹤0.01% |
23,904
-1,005
| -4% | -$48.1K |
|
2561
Fair Isaac
FICO
$37.2B
| $1.14M | ﹤0.01% |
4,207
-31,536
| -88% | -$8.57M |
|
2562
ProQR Therapeutics
PRQR
$217M
| $1.14M | ﹤0.01% |
82,339
+30,367
| +58% | +$421K |
|
2563
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$1.08B
| $1.14M | ﹤0.01% |
+57,021
| New | +$1.14M |
|
2564
Turning Point Brands
TPB
$1.84B
| $1.14M | ﹤0.01% |
24,728
-1,255
| -5% | -$57.9K |
|
2565
Triumph Financial, Inc.
TFIN
$1.36B
| $1.14M | ﹤0.01% |
38,767
-18,619
| -32% | -$547K |
|
|
HMHC
2566
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.14M | ﹤0.01% |
156,723
+83,833
| +115% | +$609K |
|
2567
First Citizens BancShares
FCNCA
$24.3B
| $1.14M | ﹤0.01% |
2,792
+1,012
| +57% | +$412K |
|
2568
Aclaris Therapeutics
ACRS
$196M
| $1.13M | ﹤0.01% |
188,841
-365,497
| -66% | -$2.19M |
|
2569
First Bancorp
FBP
$3.48B
| $1.13M | ﹤0.01% |
+98,659
| New | +$1.13M |
|
|
TRTX
2570
TPG RE Finance Trust
TRTX
$727M
| $1.13M | ﹤0.01% |
57,707
-44,685
| -44% | -$876K |
|
|
ITCI
2571
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.13M | ﹤0.01% |
92,672
-955,461
| -91% | -$11.6M |
|
2572
Columbia Emerging Markets Consumer ETF
ECON
$233M
| $1.12M | ﹤0.01% |
49,718
-30,419
| -38% | -$687K |
|
2573
Invesco DB Oil Fund
DBO
$229M
| $1.12M | ﹤0.01% |
+106,401
| New | +$1.12M |
|
|
AVLR
2574
DELISTED
Avalara, Inc.
AVLR
| $1.12M | ﹤0.01% |
20,038
-27,743
| -58% | -$1.55M |
|
2575
German American Bancorp
GABC
$1.52B
| $1.12M | ﹤0.01% |
+38,019
| New | +$1.12M |
|